Showing results (141-150 of 717) with videos related to

Sort By:
Pageof 72
Clinical Rheumatology|March 1, 1987
Serum gold concentrations during treatment with auranofinP L Van Riel, F W Gribnau, L B Van de Putte, et al.
The Journal of Rheumatology|February 24, 2000
Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazineD M van der Heijde, P L van Riel, I H Nuver-Zwart, et al.
The American Journal of Pathology|October 1, 1988
Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell wallsM F van den Broek, W B van den Berg, L B van de Putte, et al.
Arthritis and Rheumatism|October 3, 2000
The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosisR J Rodenburg, A Ganga, P L van Lent, et al.
Clinical and Experimental Immunology|March 1, 1984
Cross-reactivity of anti-DNA antibodies with proteoglycansP Faaber, P J Capel, G P Rijke, et al.
Scandinavian Journal of Immunology|January 1, 1993
Aberrant tolerance induction with cationic antigensM J Jacobs, A E van den Hoek, L B van de Putte, et al.
The Journal of Rheumatology|March 1, 1993
Development of a disease activity score based on judgment in clinical practice by rheumatologistsD M van der Heijde, M van 't Hof, P L van Riel, et al.
Annals of the Rheumatic Diseases|October 1, 1990
Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquineM J Wijnands, W A Allebes, A M Boerbooms, et al.
Arthritis and Rheumatism|October 1, 1992
Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndromeR M Hoet, I Koornneef, D J de Rooij, et al.
Seminars in Arthritis and Rheumatism|October 1, 1994
Second-line treatment in seronegative spondylarthropathiesM C Creemers, P L van Riel, M J Franssen, et al.
Pageof 72